This includes detailed personal and family history specifically addressing thyroid malignancy, particularly MTC and MEN 2 syndromes
We provide personalized, medically supervised bioidentical hormone therapy and Perimenopause/Menopause care designed to support balance, clarity, and long-term well-being guided by both clinical insight and how you feel
In comparison, research on Wegovy suggests it supports an average weight loss of around 16% after one year, 9% less than Zepbound
It should be injected subcutaneously into the upper arms, abdomen, or thighs as directed by a medical provider
Is Tirzepatide suitable for everyone, and who should consider this weight loss option
Findings In this randomized clinical trial that included 611 adults with overweight or obesity, 68 weeks treatment with once-weekly subcutaneous semaglutide vs placebo, combined with intensive behavioral therapy (and a low-calorie diet for the initial 8 weeks), resulted in reductions in body weight of 16.0% vs 5.7%, respectively
